Recalls & Warnings December 19, 2024 Force Forever Joint Pain Supplement Recalled On December 12, 2024, GNMart INC recalled all lots of Force Forever, a supplement promoted for joint pain, because FDA tests found it to contain undeclared diclofenac and dexamethasone
Other pharma players and biotech companies are knocking on the door -- and if their candidates make it successfully through clinical development and regulatory review, they could make a grand entrance
If you notice particles, discoloration, or cloudiness, do not use it
The morphological alterations exhibited in ferroptotic cells include obviously smaller mitochondria, increased membrane density of mitochondria, reduced inner mitochondrial membrane folds, and loss of structural integrity (Yagoda et al., 2007)
Nov 15: Patients with ROS1-positive non-small cell lung cancer have a new treatment option after the FDA approved Bristol Myers Squibbs Augtyro (repotrectinib) on Wednesday